Cargando…
Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition
Glycation is a nonenzymatic posttranslational modification (PTM) known to be increased in the brains of hyperglycemic patients. Alpha-synuclein (αSN), a central player in the etiology of Parkinson’s disease, can be glycated at lysine residues, thereby reducing αSN fibril formation in vitro and modul...
Autores principales: | Farzadfard, Azad, König, Annekatrin, Petersen, Steen Vang, Nielsen, Janni, Vasili, Eftychia, Dominguez-Meijide, Antonio, Buell, Alexander K., Outeiro, Tiago Fleming, Otzen, Daniel E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034100/ https://www.ncbi.nlm.nih.gov/pubmed/35314196 http://dx.doi.org/10.1016/j.jbc.2022.101848 |
Ejemplares similares
-
Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved
por: Vasili, Eftychia, et al.
Publicado: (2019) -
Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson’s Disease
por: König, Annekatrin, et al.
Publicado: (2018) -
Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
por: Dominguez-Meijide, Antonio, et al.
Publicado: (2020) -
Pharmacological Modulators of Tau Aggregation and Spreading
por: Dominguez-Meijide, Antonio, et al.
Publicado: (2020) -
Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells
por: Vasili, Eftychia, et al.
Publicado: (2022)